Table 2.
First author, year (reference) | Sample size | Location and timing of geriatric assessment† | Time needed to complete the assessment | Assessment completed by | Results of the geriatric assessment | Other information about feasibility |
---|---|---|---|---|---|---|
Geriatric assessment studied in a prospective observational study design | ||||||
Aaldriks, 2011 (18) | 202 | In hospital, not specified if in- or outpatient setting, before chemotherapy | NR | NR | 10% were frail by MMSE score, 32% by MNA score, 37% by GFI score, and 15% by IQCODE score | NR |
Aparicio, 2011 (19) | 21 | During admission or stay at inpatient ward, before chemotherapy | NR | Gastroenterologist | MGA (CGA): 43% (38%) had mental status abnormality, 43% (43%) depression, 48% (33%) dependence, 67% (71%) nutrition problems, 62% (52%) comorbidities, 38% (48%) polypharmacy, 33% (33%) living situation (including caregiver support and fall hazards in the home), and 65% (50%) low hemoglobin levels or creatinin clearance | NR |
Arnoldi, 2007 (20) | 153 | Outpatients, timing NR | NR | NR | 109 were not frail, 30 borderline, and 14 frail. The functional status in all three groups was not severely compromised | NR |
Audisio, 2008 (21)‡ | 460 | During admission, before surgery | PACE was administered in a 20-min interview | Trial nurse or student physician | Of the 90% classified as having a PS score of 0 or 1, 11% had ADL disability, 11% MMSE score <24, 23% GDS score >4, 28% moderate or severe BFI score and 35% IADL dependence, and 61% had an abnormal outcome on at least one other PACE component | NR |
Bailey, 2003 (22), 2004 (23)§ | 337 | Location NR, before treatment and after treatment | NR | NR | NR | NR |
Bamias, 2007 (24) | 34 | In hospital, not specified if in- or outpatient setting, before chemotherapy, after treatment | NR | NR | 68% had PS score >2, 65% had comorbidities, median VES-13 score was 6. Two patients were classified as group 1 (PS score 0), 24 in group 2 (PS score 1), and 6 in group 3 (PS score 2 and 3) | NR |
Bylow, 2008 (25)|| | 50 | In hospital, after at least 3 mo of ADT | NR | NR | 24% and 42% had impairments in ADL and IADL, respectively; 24% had abnormal SPMSQ score, 14% had fatigue, and 8% were nutritionally deficient. 56% had abnormal SPPB findings and 22% had fallen in the previous 3 mo | 50/58 completed assess- ment |
Castagneto, 2004 (26) | 25 | In hospital, not specified if in- or outpatient setting, before chemotherapy and after three courses of chemotherapy and at the end of treatment | NR | NR | 2 patients had ADL disability, 6 patients IADL disability, 4 patients scored positive on the GDS. 11 patients were fully independent according to CGA parameters | Two patients refused CGA evaluation |
Chaibi, 2011 (27) | 161 | In hospital, not specified if in- or outpatient setting, before chemotherapy, after tumor board recommendation | NR | NR | 47% had at least one comorbidity, 32% had ADL disability and 67% had IADL disability, 40% were at risk for malnutrition, and 25% were malnourished, 76% had geriatric interventions, 28% had higher dose intensity after CGA, and adherence to planned dose intensity was possible for 71% of patients | NR |
Clough-Gorr, 2010 (73) | 660 | Location NR, after surgery | 45min (average) | Physicians | 42% had CCI score ≥1, 85% had good self-rated health, 21% were obese, 37% had ≥1 physical limitation, 69% had good mental health, 51% had good level of social support, 43% had deficits in ≥3 domains | NR |
Extermann, 2004 (74) | 15 | Before chemotherapy, before radiation, after surgery at initial Senior Adult Oncology Program outpatient visit | NR | Multidisciplinary team | Median number of comorbidities was 5; 10 patients were at pharmacological risk, 5 were at psychosocial risk, and 8 were at nutritional risk. Patients had an average of six problems at baseline and three new problems during follow-up | 2/15 refused assessment |
Freyer, 2004 (28) | 26 | In hospital, not specified if in- or outpatient setting, before chemotherapy | NR | NR | 26 patients were included, MGA done for 19 patients (reasons why the 7 other patients were not assessed, NR) | NR |
Freyer, 2005 (29) | 83 | In hospital, not specified if in- or outpatient setting, before chemotherapy | NR | Study author | 73.5% completely independent at home, 40% on ≥4 drugs per day, mean MMSE score 27 | NR |
Fukuse, 2005 (100) | 120 | In hospital, not specified if in- or outpatient setting, before surgery | NR | Study authors | 65% had one or more comorbidities, 12.5% had a BMI <18.5 and 14.2% had a BMI >25kg/m2 (1.8% had PS score <2 and 89.7 had no ADL disability. 91.4% had a normal MMSE score | NR |
Hurria, 2006 (30) | 20 (19 were evaluable) | In hospital, not specified if in- or outpatient setting, before chemotherapy | NR | NR | Median ADL score = 18 (maximum 18), median IADL score = 20 (maximum 21), median KPS score = 80, median CCI score = 3, and median GDS score = 2 | NR |
Hurria, 2006 (32)¶ | 50 (49 were evaluable) | In hospital, not specified if in- or outpatient setting, before chemotherapy, at start and 6 mo after completion of treatment | NR | Investigator, who was also physician, or other member of study team | Pretreatment median scores: ADL = 17; IADL = 21; GDS = 2; CCI = 3; FACT-B: physical wellbeing = 26, social wellbeing = 26, emotional wellbeing = 20, functional wellbeing = 22, breast scale = 27, and total = 117. Mean BMI = 28kg/m2 | NR |
Hurria, 2006 (31)¶ | 31 (28 participated in neuro psycholo- gical tests) | Before chemotherapy, at start, and 6 mo after completion of treatment | NR | NR | Of 28 patients, 3 scored ≥2 SD below the published norms on two or more neuropsychological tests at baseline and 6 mo after chemotherapy; 8 patients scored ≥2 SD below published norms for two or more neuropsychological tests | NR |
Kothari, 2011 (33) | 60 | Outpatient preoperative clinic visit, before surgery | NR | Patient completed questionnaire | One patient died within 30 d of surgery. Major complications were observed in 8 patients and 6 patients were discharged to a location other than home | NR |
Kristjansson, 2010 (71,75)# | 182 | Location in hospital, not mentioned if in- or outpatient, before surgery | 20–80 min | Investigator, who was also a physician | 21 patients were classified as fit, 81 as intermediate, and 76 as frail according to a modified Balducci classification; 28 patients had ADL dependency, 41 had severe comorbidity, 11 took ≥8 medications/d, 16 had malnutrition, 12 had cognitive impairment, and 18 had depression. 3 died after surgery, 107 experienced complications, 83% of which were severe | Patients with some degree of cognitive impairment were interviewed in presence of their caregiver, data with regard to functional status was confirmed by nursing home staff or hospital staff |
Marenco 2008 (34) | 571 | Initial outpatient visit, before treatment | NR | NR | 18% had BMI<21kg/m2, mean CIRS score = 17, mean KPS score = 68; 28% had ADL disability, mean IADL score = 9, mean SPMSQ score = 1 | NR |
Marinello, 2008 (35) | 110 | In hospital, not specified if in- or outpatient setting, before chemotherapy | NR | NR | 50% had CIRS score >6; 55% had SPMSQ score of 0; 78% did not live alone; most had good ADL, IADL, and KPS scores (no results reported); 66% experienced some treatment failure, 13% died, 40% had grade 3 or 4 toxicity, and 17% had treatment interrupted | NR |
Massa, 2006 (36) | 10 | In hospital, not specified if in- or outpatient setting, at baseline and after 4, 8, and 12wk of treatment | The authors indicated that assess-ment was “brief” | NR | At baseline, 4 patients had a MMSE score <23 | NR |
Massa (76) | 75 | In hospital, not specified if in- or outpatient setting, before treatment | NR | NR | 26 patients were classified as fit, 23 as intermediate, and 26 as frail (unclear how defined) | NR |
Presant, 2005 (37) | 26 | In hospital, not specified if in- or outpatient setting, before chemotherapy | 10–15min | Performed by medical assistant after only 15min of training; however, some scales completed incorrectly and not evaluable (rates of evaluable responses: pain 83%, energy 96%, QOL 91%, longer ADL and IADL forms both 52% | Mean scores: ADL 22, IADL 18, pain 1.4, energy 2.1, QOL 2.3 | Study authors reported that patients found the question- naire easy to complete and useful in communi- cating symptoms to physicians; easy to administer and short time for completion; completed by patient or patient plus family with no additional help |
Puts, 2010 (94), 2011 (95)** | 112 | During visit to outpatient clinic or during admission, before treatment | Mean 45min (IQR = 40–55 min) | Investigators | 88% had ≥1 frailty marker, 54% had mobility impairment, 45% were physically inactive,40% had poor nutritional status, 28% had fatigue, 24% had cognitive impairment, 23% had mood disturbance, 21% had low grip strength, 35% had IADL disability, and 11% had ADL disability | 92% did not feel interview was too long, 78% had complete assess- ments |
Rao, 2005 (38) | 99 | During admission or stay at inpatient ward | NR | NR | 27 patients received usual in- or outpatient care, 19 received geriatric inpatient and usual outpatient care, 28 received usual inpatient and geriatric outpatient care, and 25 received geriatric in- and outpatient care | NR |
Tredan, 2007 (39) | 83 (Trial I), 75 (Trial II) | In hospital, not specified if in- or outpatient setting, before chemotherapy | NR | NR | Presence of clinical symptoms of depression, abnormal MMSE scores, and number of medications taken daily were more frequent in CC group than in CP group; at least 1 IADL dependency was reported among 38 patients in CP group, none in CC group, median HADS score = 12 in CP group | NR |
Tucci, 2009 (40) | 84 | In hospital, not specified if in- or outpatient setting, before surgery, before radiation | 15 min | Physician and registered nurse | 50% were classified as fit and 50% as unfit (Balducci classification) | NR |
Wedding, 2007 (41)†† | 427 | During admission before chemotherapy | NR | NR | In 427 patients, 35% had an ADL score <100% (indicating disability), 28.4% had an IADL score <8 (indicating disability), and 30% had ≥1 comorbidities | NR |
Geriatric assessment studied in a cross-sectional study design | ||||||
Bearz, 2007 (42) | 22 | NR | NR | NR | 5 patients were scored as unfit, 8 patients were scored as frail, and 9 were scored as fit using the investigators’ own classification scheme (frail = patients aged ≥80 y, or patients aged ≥70 y with ≥3 grade 3 comorbidities, or patients with 1 grade 4 comorbidity and an ADL disability in ≥1 items or a geriatric syndrome | NR |
Bylow, 2011 (43) | 134 | In hospital, not specified if in- or outpatient setting, case patients received at least 6 mo of ADT | NR | Data were from patients and medical chart | Using the modified Fried frailty criteria, 8.7% of patients were frail, 56.6% were prefrail vs 2.9% and 48.8%, respectively, in the control group (men with a history of prostate cancer after surgery or radiation, not on ADT and with no evidence of disease using PSA). 32% of patients vs 24% of control subjects had SPPB score <10. 14.3% of patients had reported a fall in the previous 6 mo vs 2.8% of control subjects | NR |
Di Mauro, 2000 (44) | 108 | In hospital, not specified if in- or outpatient setting, timing NR | NR | NR | Average Satariano and Ragland comorbidity score was 2.5 in the cancer patients, 33% had depressive symptoms, 21% had an MMSE score <24 | NR |
Dujon, 2006 (45) | 41 | In hospital, not specified if in- or outpatient setting, before treatment | 30min (average) | Two investigators, who were also physicians | 50% had ADL disability and 95% had IADL disability, 29% had a MMSE score <24, 17% had a PINI score >20, average CCI score was 2.7 | NR |
Extermann, 1998 (46) | 203 | Initial visit to Senior Adult Oncology Program | NR | Multidisciplinary team | 79% had no ADL disability, 44% had no IADL disability, 31% had ECOG PS score of 0, 64% had a CCI score of 0, and 6% had a score of 0 on CIRS-G | NR |
Girones, 2010 (47) | 91 | Follow-up visit in outpatient oncology clinic | 30–40 min | Investigator, who was also a physician | 4% had no ADL disability, 37% had no IADL disability, 10% had PS score of 2, median CCI score was 2, 28% had a geriatric syndrome, 37% were defined as frail according to the Balducci classification | NR |
Girre, 2008 (48) | 105 | In geriatric oncology clinic, timing NR | 10 min | Investigator, who was also a physician | 58% were independent in ADL, 46% were independent in IADL, 20% had good nutritional status, 20% had impaired mobility, 53% had depressive symptoms, 33% had ≥2 comorbid conditions, 74% took ≥3 drugs | NR |
Hurria, 2005 (88) | 43 agreed to participate (40 partici- pated) | The assessment was completed in physician’s office during outpatient visit | Mean time to complete = 27min (SD = 10min, range = 8–45min) | Patient and interviewer together | 63% had the maximum IADL score, 28% reported one or more falls, 8% reported clinically significant anxiety or depression, 45% had limitations in social activities, 5% had low BMI, and 48% reported weight loss | 78% did not need assistance to complete, 83% said the assessment was easy to understand, 90% were satisfied with the length of the question- naire, 100% stated no items were upsetting |
Hurria, 2007 (89)‡‡ | 250 (245 completed survey) | The patients were mailed the questionnaire prior to appointment or received it at their appointment | Mean time to complete = 15min (SD = 10min, range = 2–60min). ESL patients took most time | Patient | Mean ADL score 12 (maximum 14), 49% had IADL disability, 74% had KPS score >70%, 21% had a fall, 94% had ≥1 comorbidity, 21% rated their distress score >5, 20% were underweight, and 26% had lost weight | 78% completed without assistance; of those who needed assistance, 19% got it from friends or family. 94% said that the question- naire was easy to under- stand and 91% were satisfied with its length. 89% had complete question- naires |
Hurria, 2009 (90)‡‡ | 245 | Patients were mailed the questionnaire prior to appointment or received it at their appointment | Mean time to complete = 15min (SD = 10min, range = 2–60min). ESL patients took most time | Patient | 41% reported a distress score of ≥4 | |
Ingram, 2002 (85) | 154 | Questionnaire was sent 2wk prior to scheduled appointments for initial consultations and follow-up appointments | NR | Patient | Mean number of medications was 6, mean number of comorbidities was 5, 69% had ADL disability, 58% had IADL disability, mean pain score was 4.2 (range = 0–10), 76% rated their health as fair or poor, 32% and 26% scored positive for depression and anxiety, respectively | Response rate to mail question- naire was 64% |
Kellen, 2010 (49) | 113 | NR | It took 15min to complete the three screening instruments, and 30min for the CGA | Trained medical staff | GFI classified 31% as vulnerable, the VES-13 classified 49% as vulnerable (classification by aCGA NR) | NR |
Kim, 2011 (50) | 65 | In hospital, not specified if in- or outpatient setting, before chemotherapy | NR | Trained geriatric nurse | 25% had CCI score ≥2, 23% had ADL disability, 14% had IADL disability, 51% had mild cognitive impairment, 40% had depression. Frail patients had statistically significantly poorer PS and worse global health and QOL scores compared with nonfrail patients | NR |
Luciani, 2010 (51) | 419 | In hospital, not specified if in- or outpatient setting, before treatment | NR | NR | 53% were vulnerable according to the VES-13, 30% had ADL disability, and 25% had IADL disability | NR |
Lynch, 2007 (52) | 85 | In hospital, not specified if in- or outpatient setting, timing NR | NR | Social work intern | Most frequently reported need was emotional support, followed by caregiver support and transportation issues | NR |
Mantovani, 2004 (53) | 84 older cancer patients, 59 adult cancer patients | In hospital, not specified if in- or outpatient setting, timing NR | NR | NR | 15% of elderly patients had severe functional impairment, 46% had IADL disability, 16% had depression according to BDI scores, 41% had MMSE score <24, 29% had MNA score <12 | NR |
Mohile, 2007 (78)|| | 58 agreed to participate and 50 had data | In hospital, not specified if in- or outpatient setting, timing NR | NR | NR | 50% were impaired according to the VES-13 score (60% according to CGA) | 50/58 had complete assessment |
Mohile, 2009 (54) | 12 480 | NR | NR | Investigator used data from databases | Persons with a history of cancer had a higher prevalence of ADL and IADL disabilities and geriatric syndromes, low self-rated health, a VES-13 score >3, and frailty according to the Balducci classification compared with persons without cancer | NR |
Molina- Garrido, 2011 (55) | 41 | In hospital, not specified if in- or outpatient setting, before chemotherapy | NR | Investigator who was also physician | 37% had ADL disability, 46% had IADL disability, 2% were at social risk, 46% had no comorbidity, 42% had 1 comorbidity, 10% had 2 comorbidities, and 2% had 3 comorbidities, 20% had a cognitive deficit using the Pfeiffer scale, 34% were at risk of malnutrition, and 39% took >4 drugs | NR |
Molina- Garrido, 2011 (56) | 99 | After oncology service referral, during outpatient visit, timing NR | Mean time needed to complete CGA = 12.87min (range = 9.5–20min) | Investigator who was also a physician | 87.5% were at risk of frailty, 65.3% were ADL dependent, 75% were IADL dependent, 29.3% had some degree of cognitive impairment, 46.7% were at risk of malnutrition | Patients’ opinions regarding length of survey: very long (36.4%), short (0%), suitable (63.6%); difficulty: difficult (30.3%), acceptable (69.7%), easy (0%) |
Monfardini, 1996 (57) | 30 | During admission or stay at inpatient ward, during routine visits | Mean = 27.4 min (range = 20–45min) | Two physicians | Patients were moderately disabled, had several depressive symptoms and good cognitive functioning. No actual numbers reported | NR |
Overcash, 2007 (58) | 165 | Patients seen at Senior Adult Oncology Program, not specified if in- or outpatient setting, timing NR | 30 min | Interview with trained data collectors | 37 patients had experienced a fall | NR |
Overcash 2008 (77) | 352 | Patients seen at Senior Adult Oncology Program outpatient clinic | 30 min | Interview with trained data collectors | The population was divided into three groups: no treatment, treatment, and geriatric. Mean ADL scores were 17.5, 17.6, and 16.7, respectively; mean GDS scores were 2.1, 2.9, and 2.4, respectively; mean MMSE scores were 28.4, 27.9, and 25.0, respectively; and percentages with a fall were 25%, 33%, and 42%, respectively. | NR |
Pignata, 2008 (59) | 26 | In hospital, not specified if in- or outpatient setting, before chemotherapy | NR | NR | 65.4% had no ADL disability, 69.2% had at least 1 IADL disability, and most patients had at least 1 comorbidity, 50% had 2 or more comorbidities | NR |
Pope, 2006 (60)‡ | 460 | During admission, before surgery | PACE was administered in a 20-min interview | Trial nurse or student physician | 33.3% had 1 or more comorbidities. 85.0% and 59.8% were independent in ADL and IADL, respectively; 87.8% had normal MMSE score, 73.3% were not depressed, 69% had no or mild fatigue, and 91% had PS score <2 | |
Repetto, 2002 (61) | 363 | During admission or stay at inpatient ward | 20min (average) | Data used in assessment was obtained from medical chart and patient questionnaire | 74% had PS score <2, 86% were independent in ADL and 52% were independent in IADL. 41% had 1 or more comorbidities, 27% had abnormal MMSE scores, and 40% had 1 or more depressive symptoms | NR |
Retornaz, 2008 (93) | 50 | Patients were assessed for the study when they were admitted or during initial or routine outpatient follow-up visit | NR | Investigator who was also a physician | 12% were completely independent, 42% had frailty markers but no disability, 30% had an IADL disability but no ADL disability, and 16% had an ADL disability. The most prevalent frailty markers were nutrition (62%), mobility (58%), physical inactivity (42%), cognition (42%), grip strength (26%), mood (22%), and fatigue (12%) | NR |
Roche, 1997 (62) | 50 | After initial visit to geriatric oncology outpatient clinic | NR | Patients were seen in the geriatric oncology clinic, NR who conducted the assessment | 74% had no ADL disability and 56% had disability in IADL functioning. 27% showed cognitive deficits, 24% were considered to be depressed. The study participants who were not receiving active cancer treatment were more functionally impaired in ADL (P = .006) and IADL (P = .004) compared with those who were receiving active cancer treatment | NR |
Serraino, 2001 (63) | 303 | During admission or stay at inpatient ward | NR | Interview with geriatrician | 17% had ADL disability, 59% had IADL disability, and 13% had limitations in taking medications. 54% of patients aged <80 y had PS score of 2–4 compared with 22% of patients aged 65–69 y (P < .001); presence of comorbidity was the same for these two age groups; frequency of IADL limitations more pronounced in oldest group aged ≥80 y of elderly patients compared with those aged 65–69 y (P = .03) | NR |
Siegel, 2006 (64) | 25 | At outpatient clinic visit, timing NR | Assessment (three performance tests) took <5min | NR | Most had ECOG PS score of 1, the variance was highest for grip strength, less for TUG, and least for the Tinetti test. Among patients with ECOG PS score of 1, these measures were able to further identify subgroups with different functional status | NR |
Stauder, 2010 (65) | 78 | During admission or stay at inpatient ward | NR | NR | Median values: KPS score = 90, ADL score = 100, WHO PS score = 1, VES-13 score = 2, IADL score = 7, GSD score = 7.5, CCI score =1, CIRS-G score = 5.5, MMSE score = 27, BMI = 24.7kg/m2 | NR |
To, 2010 (66) | 200 | Location NA, before initial medical oncology visit | The first 100 patients needed 17min (average) to complete | Patients completed a questionnaire that was mailed prior to the first appointment | 45% had ADL disability and 41% had IADL disability, 35% had KPS score <70, 22% had a fall, 34% had weight loss >5% in the last 6 mo, 26% had limited social support, 39% received some support service, 22% had memory problems; 60% were classified as vulnerable, 28% as fit, and 13% as frail using own classification scheme (4–5 factors of assessment of concern = frail, 1–3 factors of concern = vulnerable, and 0 factors = fit). Those who were frail had worse functional status | 84% reported complete satisfaction with length, style, and clarity. Patients or proxies were expected to complete questionnaire before appointment, but in some cases, a geriatric oncology nurse assisted |
Venturino, 2000 (67) | 45 | In hospital, not specified if in- or outpatient setting, timing NR | NR | NR | Descriptive (% of patients): 11.2% had PS score ≥2, 20% was ADL dependent (impaired in at least 1 item), and 51.2 % was IADL dependent (impaired in at least 1 item). Of all patients, 46.7% screened GDS positive and 24.5% scored impaired on the MMS. Of all patients, 64.4% had arthrosis or arthritis, 44.4% had hypertension, 35.5% had vascular diseases, 31.1% had digestive disease, and 28.8% had CNS diseases (excluding stroke) | NR |
Wedding, 2007 (68)†† | 477 | Admitted to hospital, before chemotherapy | NR | NR | In group A (elderly cancer patients), 36.8% needed help with IADL, 27.5% had a KPS score of 10%–70%, and 37% had 2 or more comorbidities. In group B (younger cancer patients), 18.7% needed help with IADL, 18.5% had a KPS score of 10%–70%, and 16% had 2 or more comorbidities. In group C (elderly noncancer patients), 24.2% needed help with IADL, 14% had a KPS score of 10%–70%, and 42 % had two or more comorbidities | NR |
Wedding, 2007 (99) | 200 | During routine oncology visit in outpatient setting | Median duration of assessment 20min (range = 9–47min) | Two physicians | 50% had maximum ADL score, 54% had maximum IADL score, 43% had poor nutritional status or were at risk, 8% had cognitive impairment using MMSE score, 23% had increased risk of falls, 16% had ≥2 comorbidities. According to the Balducci classification, 25% were fit, 25.5% were vulnerable, and 49.5% were frail. Physicians identified 64% as fit, 32.4% as vulnerable, and 3.2% as frail. The CGA identified a mean of 1.3 problems in those identified as fit, 2.3 problems in those identified as vulnerable, and 4.2 problems in those identified as frail | NR |
Geriatric assessment studied in retrospective studies or chart reviews | ||||||
Barthelemy, 2011 (98) | 192 (93 underwent geriatric assess- ment) | After hospital referral, not clear when and where the assessment took place | NR | NR | 36 patients were fit, 47 were vulnerable, and 10 were frail using the Balducci classification. Median age of fit patients was 75.4 y, vulnerable patients 80.3 y, and frail patients 87.4 y | NR |
Basso, 2008 (79) | 117 | Admitted to medical oncology ward, before chemotherapy | NR | Multidisciplinary team | 33.3% were fit, 32.5% were vulnerable, and 34.2% were frail using the Balducci classification. 39.3% received an “elderly friendly” regimen, the others received a standard regimen | NR |
Cudennec, 2007 (72) | 124 | During admission or stay at inpatient ward, outpatient (not specified) | Within 1 h | NR | Assessment was done in 82% of inpatients and 18% of outpatients presenting with gastrointestinal cancer. Average MMSE score was 23, 43% had probable depression, 40% had abnormal TUG score, 26% required a more thorough geriatric evaluation | NR |
Cudennec, 2010 (84) | 57 | In hospital, not specified if in- or outpatient setting, before treatment decision | The Simplified Geriatric Evaluation took 1h (average) | NR | All patients lived at home and took on average 6.8 drugs per day, 51% had MMSE score <26, 47% were suspected of having depression, 68% were at risk for falls, and 44% had loss of autonomy. 5% were classified as fit, 68% were intermediate, and 42% were vulnerable. All patients in the fit group were considered able to receive optimal treatment, compared with none in vulnerable group and some in the intermediate group | NR |
Flood, 2006 (92) | 119 | During admission to hospital | NR | Data from medical chart | Of the 11 patients who had a positive GDS score, 7 had depression documented by physician team. 42 patients had an abnormal Clock Construction Test score and 25 patients had an abnormal Short Blessed Test score, but 36% of all patients had cognitive impairment according to treating team. Of all patients, 45% had ADL disability and 74% had IADL disability, 87% were able to return home, 35% had a history of weight loss | NR |
Fratino, 1999 (69) | 363 | During admission or stay at inpatient ward | NR | Patient filled out questionnaire and data from chart | 26% had a poor PS score, 41% had comorbid conditions, 14% had ADL limitations, 48% had IADL limitations, 27% had poor MMSE scores, and 40% had depressive symptoms | NR |
Garman, 2004 (86) | 102 admitted, 36 with cancer | During admission or stay at inpatient ward | NR | Data from medical chart | The mean number of comorbid conditions was 4.6, the mean number of symptoms was 2.5, and the mean KPS score was 55%. 53% had cognitive impairment | NR |
Koroukian, 2006 (91)§§ | 2552 | Location NR, during admission to Medicare Home Health Care | NR | Investigator used databases | The proportions of patients with no comorbidity, disability, or geriatric syndromes were 26.4% (breast cancer), 12% (prostate cancer), and 14% (colorectal cancer). The proportions with comorbidity, disability, and geriatric syndromes were 11.7%, 24.7%, and 15.7%, respectively. With increasing age, the proportion of persons with no comorbidity, disability, or geriatric syndromes declined | NR |
Koroukian, 2010 (80)§§ | 1009 | Location NR, during admission to Medicare Home Health Care | NR | Investigator used databases | 15% had 1 functional limitation, 22% had ≥2 functional limitations, 31% had 1 geriatric syndrome, 17% had ≥2 geriatric syndromes, 29% had 1 comorbidity, 22% had ≥2 comorbidities | NR |
Overcash, 2005 (81), 2006 (83) || || | 352 | In hospital, not specified if in- or outpatient setting, at initial visit to Senior Adult Oncology Program | NR | Chart review | 500 charts were reviewed, no other information presented | NR |
Retornaz, 2008 (82) | 183 | Admitted to hospital, before chemotherapy | NR | Chart review | 67% admitted for acute medical problems and 33% admitted for diagnosis. More than 10% had geriatric syndromes, 60% took ≥3 medications, 53% had ADL disability and 64% had IADL disability, 67% had mobility impairments and malnutrition, 50% had depressive symptoms | NR |
Rollot-Trad, 2008 (97) | 54 | In hospital, not specified if in- or outpatient setting, timing NR | NR | Chart review | 74% had a CCI score of 0–3, 22% had a CCI score of 4–5, and 2% had a CCI score >5; 39% took 4 or more medications, 69% had social support, 98% lived at home, 24% were depressed; 61% were independent in ADL, 63% were independent in IADL, 27% had an MMSE score <24 | NR |
Sorio, 2006 (70) | 17 | In hospital, not specified if in- or outpatient setting, timing NR | NR | NR | 11 patients were considered not to have an increased risk for adverse outcomes (also called geriatric risk in this study) and 6 patients had a geriatric risk score of 1, which was defined as: PS 2, taking more than two medical treatments, and/or ADL or IADL disability | NR |
Terret, 2004 (87) | 60 | Patients seen in geriatric oncology program (not specified if in- or outpatient setting), before treatment | Mini-CGA lasted 90–120 min | NR | 66% had an ADL disability and 87% had an IADL disability; all patients had clinically significant comorbidity; 50% were at risk for falls; 67 had a GDS score <15, 45% had cognitive disorders, and 65% were malnourished or at risk of malnutrition | NR |
Yonnet, 2008 (96) | 363 | In hospital, not specified if in- or outpatient setting, timing NR | NR | Chart review | According to the Standardized Geriatric Evaluation (Evaluation Gériatrique Standardisée) score, patients aged ≥70 y had statistically significantly more disability, higher CCI score, underwent radiotherapy and chemotherapy less often, and had symptomatic treatment more compared with the patients aged <70 y. Those who were frail (Balducci classification) received more treatment consisting of only radiation compared with those classified as fit or vulnerable, whereas those classified as fit most often received chemotherapy alone or in combination with surgery and radiation | NR |
*NA = not applicable; NR = not reported; aCGA = abbreviated geriatric assessment; ADL = activities of daily living; ADT = androgen deprivation therapy; AGS = American Geriatric Society; BDI = Beck Depression Inventory; BFI = Brief Fatigue Inventory; BMI = body mass index; BUN = blood urea nitrogen; CC = carboplatin and cyclophosphamide; CP = carboplatin and paclitaxel; CGA = comprehensive geriatric assessment; CCI = Charlson comorbidity index; CIRS-G = Cumulative Illness Rating Scale–Geriatric; DLCL = diffuse large cell lymphoma; ECOG = Eastern Collaborative Group Oncology; PS = performance status; ESL = English as a second language; FACT-B = Functional Assessment Cancer Treatment–Breast; GDS = Geriatric Depression Scale; GFI = Groningen frailty indicator; HADS = Hospital Anxiety and Depression Scale; IADL = instrumental activities of daily living; IQCODE = Informant Questionnaire on Cognitive Decline in the Elderly; IQR = interquartile range; KPS= Karnofsky Performance Status; MGA = multidimensional geriatric assessment; MMSE = Mini Mental State Examination; MNA = Mini Nutritional Assessment; NSI = nutritional risk screening; OARS = Older Americans Resources and Services; PACE = Preoperative Assessment of Cancer in the Elderly; PINI = Prognostic Inflammatory and Nutrition Index; PS = Performance Status; PPT = physical performance test; QOL = quality of life; SPMSQ = Short Portable Mental Screening Questionnaire; SPPB = Short Physical Performance Battery; TUG = Timed Up and Go test; VES-13 = Vulnerable Elder Survey-13 items; SIC = Satariano comorbidity index.
†Location = inpatient or outpatient setting; timing of geriatric assessment = before, during, or after treatment.
‡Articles reporting on the same study.
§Articles reporting on the same study.
||Articles reporting on the same study.
¶Articles reporting on the same study.
#Articles reporting on the same study.
**Articles reporting on the same study.
††Articles reporting on the same study.
‡‡Articles reporting on the same study.
§§Articles reporting on the same study.
|| ||Articles reporting on the same study.